Elevated expressions of NTCP on NK cells from liver fibrosis of metabolic dysfunction-associated steatohepatitis patients are associated with increased bile acid uptake that impaired their function via STAT signaling pathway

被引：0
|
作者：
Salhab, Ahmad [1 ]
Amer, Johnny [1 ]
Safadi, Rifaat [1 ]
机构：
[1] Hadassah Hebrew Univ Hosp, Liver Inst, Jerusalem, Israel
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OS-100
引用
收藏
页码：S63 / S63
页数：1
相关论文
共 7 条
  • [1] Imbalance of mitochondrial fusion in peripheral blood mononuclear cells is associated with liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis
    Kunlayawutipong, Thanaput
    Apaijai, Nattayaporn
    Tepmalai, Kanokkan
    Kongkarnka, Sarawut
    Leerapun, Apinya
    Pinyopornpanish, Kanokporn
    Soontornpun, Atiwat
    Chattipakorn, Siriporn C.
    Chattipakorn, Nipon
    Pinyopornpanish, Kanokwan
    HELIYON, 2024, 10 (06)
  • [2] Low thyroid function is associated with an increased risk of advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease
    Fan, Hong
    Li, Lili
    Liu, Zhenqiu
    Zhang, Pengyan
    Wu, Sheng
    Han, Xinyu
    Chen, Xingdong
    Suo, Chen
    Cao, Liou
    Zhang, Tiejun
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [3] Low thyroid function is associated with an increased risk of advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease
    Hong Fan
    Lili Li
    Zhenqiu Liu
    Pengyan Zhang
    Sheng Wu
    Xinyu Han
    Xingdong Chen
    Chen Suo
    Liou Cao
    Tiejun Zhang
    BMC Gastroenterology, 23
  • [4] Lupeol improves bile acid metabolism and metabolic dysfunction-associated steatotic liver disease in mice via FXR signaling pathway and gut-liver axis
    Qin, Dongmei
    Pan, Peiyan
    Lyu, Bo
    Chen, Weijun
    Gao, Yuefeng
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 177
  • [5] In Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Clinically Significant Pruritus is Associated with High Serum Bile Acid (BA) Level and Advanced Fibrosis (AF)
    Younossi, Zobair
    Estep, James M.
    Felix, Sean
    Lam, Brian
    Mukherjee, Sumanta
    Swift, Brandon
    Casillas, Linda
    Ribeiro, Andrea
    Hunnicutt, Jake
    McLaughlin, Megan
    Racila, Andrei
    Nader, Fatema
    Stepanova, Maria
    JOURNAL OF HEPATOLOGY, 2024, 80 : S476 - S476
  • [6] Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores
    Targher, Giovanni
    Mantovani, Alessandro
    Byrne, Christopher D.
    Wang, Xiao-Bo
    Yan, Hua-Dong
    Sun, Qing-Feng
    Pan, Ke-Hua
    Zheng, Kenneth I.
    Chen, Yong-Ping
    Eslam, Mohammed
    George, Jacob
    Zheng, Ming-Hua
    GUT, 2020, 69 (08) : 1545 - +
  • [7] Final results from the phase 3 REGENERATE trial evaluating the effects of obeticholic acid in patients with pre-cirrhotic fibrosis due to metabolic dysfunction-associated steatohepatitis
    Sanyal, Arun J.
    Loomba, Rohit
    Anstee, Quentin M.
    Ratziu, Vlad
    Kowdley, Kris V.
    Lawitz, Eric
    White, Christopher
    Sawhney, Sangeeta
    Capozza, Thomas
    Leyva, Rina
    Younossi, Zobair
    Rinella, Mary E.
    Abdelmalek, Manal F.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S95 - S95
1